Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort

scientific article published on January 2010

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GCC.20717
P698PubMed publication ID19787792
P5875ResearchGate publication ID26854653

P50authorChristopher PorembaQ1086901
Massimo SerraQ38549348
Ola MyklebostQ41845092
Anne-Marie Cleton-JansenQ45924326
P2093author name stringThomas Aigner
Anne-Marie Cleton-Jansen
Pancras C W Hogendoorn
Helmut E Gabbert
Enrique de Alava
Carlos Mackintosh
Karl-Ludwig Schaefer
Wolfgang Huckenbeck
Leonardo A Meza-Zepeda
Stine H Kresse
Horst Buerger
Stefan Baldus
Laura Ottaviano
Uwe Rogel
Melanie Gajewski
P2860cites workComparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling dataQ21266587
A new member of the ETS family fused to EWS in Ewing tumorsQ24317176
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificationQ24530153
Surfing the p53 networkQ28032484
Cancer statistics, 2001Q28189339
Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradationQ28201673
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanomaQ29614282
Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technologyQ31046036
The MDM2 gene amplification databaseQ34672224
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumorsQ35186715
Mechanisms of sarcoma developmentQ35210018
Assessing p53 in clinical contexts: unlearned lessons and new perspectivesQ36332531
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcomaQ36496709
A gene involved in control of human cellular senescence on human chromosome 1qQ36649408
p53 and its isoforms in cancerQ36885363
Prognostic significance of p16 INK4a alteration for Ewing sarcoma: a meta-analysisQ36895474
Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomasQ38462096
Cross-contamination of cells in cultureQ38583207
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapyQ40009768
Evaluation of methods to detect p53 mutations in ovarian cancerQ73599393
Prognostic impact of P53 status in Ewing sarcomaQ74199510
Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded studyQ79735484
Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expressionQ80387809
SarcomaQ81537795
Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcomaQ40030553
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.Q40126904
Characterization of human cells transformedin vitro by n-methyl-n'-nitro-n-nitrosoguanidineQ40478781
DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clonesQ40666348
Anin VitroModel to Study Mesenchymal– Epithelial TransformationQ41036143
Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.Q41183571
Inactivation of p53 gene in human and murine osteosarcoma cellsQ41640482
Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.Q42816542
Redundancy of autocrine loops in human osteosarcoma cells.Q42820019
Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponseQ45230556
Molecular Analysis of Ewing's Sarcoma: Another Fusion Gene, EWS‐E1AF, Available for DiagnosisQ48022580
Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA".Q51722318
Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin.Q52828622
Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma.Q52833927
Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysisQ54699962
Cancerous tissues in forensic genetic analysisQ56996395
Insights from genomic microarrays into structural chromosome rearrangementsQ59196070
TP53Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter StudyQ61909878
P4510describes a project that usesSaOS-2Q7420876
U2OSQ28473037
OHSQ38098672
IOR/MOSQ54897866
IOR/OS10Q54897868
IOR/OS14Q54897869
IOR/OS15Q54897871
IOR/OS18Q54897874
IOR/OS9Q54897877
IOR/SARGQ54897879
JJ012Q54898950
KPDQ54900430
MG-63Q54905408
MHMQ54905565
MNNG/HOS Cl #5Q54906271
RD-ESQ54949536
143BQ54581813
A-673Q54606055
CADO-ES1Q54808333
ch-2879Q54811597
CHP-100Q54813260
HALQ54872386
HOSQ54890160
RM-82Q54950632
SJSA-1Q54953586
SK-ES-1Q54953654
SK-N-MCQ54954478
STA-ET-1Q54955761
STA-ET-2.1Q54955771
SW1353Q54971078
TC-71Q54971816
VH-64Q54993098
WE-68Q54993696
ZK-58Q54995932
P433issue1
P921main subjectcell lineQ21014462
bone neoplasmQ1328805
P304page(s)40-51
P577publication date2010-01-01
P1433published inGenes, Chromosomes and CancerQ5532697
P1476titleMolecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort
P478volume49